Adrenomedullin (22-52) (human) structure
|
Common Name | Adrenomedullin (22-52) (human) | ||
---|---|---|---|---|
CAS Number | 159899-65-7 | Molecular Weight | 3576.03 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C159H252N46O48 | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Use of Adrenomedullin (22-52) (human)Adrenomedullin (AM) (22-52), human is an adrenomedullin receptor antagonist, and also antagonizes the calcitonin generelated peptide (CGRP) receptor in the hindlimb vascular bed of the cat. |
Name | Adrenomedullin(22-52)(Human) |
---|---|
Synonym | More Synonyms |
Description | Adrenomedullin (AM) (22-52), human is an adrenomedullin receptor antagonist, and also antagonizes the calcitonin generelated peptide (CGRP) receptor in the hindlimb vascular bed of the cat. |
---|---|
Related Catalog | |
Target |
Adrenomedullin receptor, CGRP receptor[1] |
In Vitro | Adrenomedullin (AM) (22-52), human shows no effect on hindlimb perfusion pressure responses to adrenomedullin (ADM) at 120 nmol. However, Adrenomedullin (AM) (22-52), human selectively and reversibly decreases vasodilator responses to human calcitonin generelated peptide (hCGRP) at 30 nmol, with similar effect to that of CGRP antagonist[1]. |
References |
Molecular Formula | C159H252N46O48 |
---|---|
Molecular Weight | 3576.03 |
Storage condition | −20°C |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Adrenomedullin receptor binding sites in rat brain and peripheral tissues.
Eur. J. Pharmacol. 474 , 165-174, (2003) The existence of specific adrenomedullin receptor binding sites was investigated using the agonist peptide fragment [125I]human adrenomedullin-(13-52) in rat brain, lung and vas deferens homogenates. ... |
|
Adrenomedullin is anti-apoptotic in osteoblasts through CGRP1 receptors and MEK-ERK pathway.
J. Cell Physiol. 215 , 122-128, (2008) Adrenomedullin (ADM) has been shown to mediate multifunctional responses in cell culture and animal system such as regulation of growth and apoptosis. ADM stimulates the proliferation of osteoblasts i... |
|
Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis.
Oncogene 22 , 1238-1242, (2003) Since it is reported that adrenomedullin (AM) upregulated by hypoxia inhibits hypoxic cell death, we examined the effects of AM antagonist (AM C-terminal fragment; AM(22-52)) on the growth of pancreat... |
MFCD00282038 |
Adrenomedullin (AM) (22-52), human |